# A Single Oral Dose, Crossover Comparative PK Study of WD-1603 in Healthy Subjects Under Fasting Conditions

> **NCT04553978** · PHASE1 · UNKNOWN · sponsor: **Hong Kong WD Pharmaceutical Co., Limited** · enrollment: 8 (estimated)

## Conditions studied

- Parkinson Disease

## Interventions

- **DRUG:** WD-1603

## Key facts

- **NCT ID:** NCT04553978
- **Lead sponsor:** Hong Kong WD Pharmaceutical Co., Limited
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE1
- **Study type:** INTERVENTIONAL
- **Status:** UNKNOWN
- **Start date:** 2020-09-18
- **Primary completion:** 2021-03-18
- **Final completion:** 2021-03-18
- **Target enrollment:** 8 (ESTIMATED)
- **Last updated:** 2020-09-22


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT04553978

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT04553978, "A Single Oral Dose, Crossover Comparative PK Study of WD-1603 in Healthy Subjects Under Fasting Conditions". Retrieved via AI Analytics 2026-06-05 from https://api.ai-analytics.org/clinical/NCT04553978. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*